Retinal Detachment Diagnostic Market Report 2026

The retinal detachment diagnostic market size has grown strongly in recent years. It will grow from $1.42 billion in 2025 to $1.54 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increase in diabetic eye disease cases, growth in ophthalmic imaging centers, rising awareness of retinal disorders, expansion of hospital eye clinics, early adoption of oct scanners.

The retinal detachment diagnostic market size is expected to see strong growth in the next few years. It will grow to $2.13 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to growing aging population, rising demand for early vision diagnosis, expansion of remote eye screening programs, increasing investment in ophthalmic imaging, higher prevalence of myopia and diabetes. Major trends in the forecast period include rising use of optical coherence tomography imaging, growing adoption of teleophthalmology screening services, expansion of digital fundus photography systems, increasing use of AI assisted retinal image analysis, higher deployment of portable ophthalmic ultrasound devices.

The growing prevalence of myopia and high myopia cases is expected to drive the growth of the retinal detachment diagnostic market in the future. Myopia and high myopia refer to the increasing incidence of shortsightedness and severe shortsightedness, which impair distance vision and heighten the risk of serious eye complications. The rise in myopia and high myopia due to prolonged screen exposure and reduced outdoor activity increases eye strain, causing earlier onset and faster progression of refractive errors. Retinal detachment diagnostics support individuals with myopia and high myopia by enabling early detection of retinal complications, facilitating timely clinical intervention, and reducing the risk of severe vision loss. For example, in July 2025, according to Woo University, a US-based nonprofit, 30% of the global population is currently myopic, and this figure is projected to reach nearly 50% by 2050, affecting around 5 billion people. Hence, the growing incidence of myopia and high myopia cases is propelling the retinal detachment diagnostic market.

Leading companies operating in the retinal detachment diagnostic market are focusing on developing advanced imaging solutions, such as ultra-widefield optical coherence tomography (OCT), to enhance detection accuracy, improve visualization of the peripheral retina, and support early identification of retinal tears and detachments. Ultra-widefield OCT refers to an imaging technology that captures high-resolution, wide-angle views of the retina, enabling clinicians to detect subtle or peripheral retinal abnormalities that might otherwise be missed. For example, in March 2025, Optos PLC, a UK-based retinal imaging company, launched MonacoPro, its next-generation ultra-widefield SLO and spectral domain retinal imaging system. Designed to assist eye care professionals with improved diagnostic precision and workflow efficiency, MonacoPro features high-quality OCT imaging, integrated 200° optomap visualization, and the new AreaAssist tool, which automates area measurement and analysis, collectively enhancing clinicians’ ability to detect retinal detachments and other ocular pathologies.

In February 2025, EssilorLuxottica SA, a France-based ophthalmic instruments manufacturing company, acquired Cellview Imaging for an undisclosed amount. Through this acquisition, EssilorLuxottica aims to broaden its ophthalmic instruments and med-tech solutions portfolio by integrating Cellview’s ultra-widefield retinal imaging technology, improving early diagnosis of retinal pathologies, and advancing vision health care globally. Cellview Imaging Inc. is a Canada-based company providing innovative retinal imaging solutions, including retinal detachment diagnostics and ultra-widefield retinal cameras for early detection of retinal pathologies.

Major companies operating in the retinal detachment diagnostic market are Canon Inc., Essilor International S.A., NIDEK Co Ltd., Alcon Inc., Nikon Corporation, Kowa Company Ltd., Carl Zeiss Meditec AG, Topcon Corporation, Tomey Corporation, Forus Health Pvt Ltd., Reichert Technologies, Optos plc, Revenio Group, Visionix USA Inc., Haag-Streit Group, Optomed Plc, Remidio Innovative Solutions, Intelligent Retinal Imaging Systems (IRIS), Santec Corporation, and D‑EYE Srl.

Tariffs are influencing the retinal detachment diagnostics market by increasing the import cost of ophthalmic imaging devices and precision optical components. Duties on scanners, cameras, and ultrasound systems are raising equipment prices for clinics and hospitals. Imaging based diagnostic segments are most affected due to reliance on imported hardware. Regions that depend on global medical device supply chains are seeing slower procurement cycles. Providers are renegotiating supplier contracts and phasing upgrades. At the same time, tariffs are encouraging local assembly of ophthalmic devices and regional servicing networks. This is improving domestic device support capacity.

The retinal detachment diagnostic market research report is one of a series of new reports that provides retinal detachment diagnostic market statistics, including retinal detachment diagnostic industry global market size, regional shares, competitors with a retinal detachment diagnostic market share, detailed retinal detachment diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the retinal detachment diagnostic industry. This retinal detachment diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Retinal detachment diagnostics include medical examinations, imaging methods, and clinical tests used to detect, verify, and evaluate the severity and spread of retinal separation from underlying eye tissues. These diagnostics assist eye specialists in determining the type, location, and cause of detachment to guide timely intervention and prevent permanent vision impairment.

The principal disease types in retinal detachment diagnostics are tractional retinal detachment and rhegmatogenous retinal detachment. Tractional retinal detachment occurs when fibrous or fibrovascular tissue pulls the retina away from its underlying layer. Diagnostic procedures involve tools such as fundus photography, ophthalmoscopy, optical coherence tomography scanners, fundus cameras, ophthalmic ultrasound imaging systems, ophthalmic A-scan ultrasound, and ophthalmic B-scan ultrasound. These solutions leverage technologies including imaging-based diagnostics, non-imaging clinical examinations, and advanced digital ophthalmic systems. Applications include vitreo-retinal disorders, cataracts, glaucoma, and refractive disorders, with end-users such as hospitals, eye clinics, academic and research laboratories, and other relevant organizations.

The retinal detachment diagnostic market includes revenues earned by entities through retinal imaging services, optical coherence tomography services, fundus photography services, ophthalmic ultrasound services, diagnostic interpretation services, teleophthalmology services, screening and referral services, and clinical consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.